ShangPharma Corp. (SHP) Misses Q3 EPS by 5c; Lowers FY12 Revs Outlook
Tweet Send to a Friend
ShangPharma Corp. (NYSE: SHP) reported Q3 EPS of $0.15, $0.05 worse than the analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
